Hauptinhalt
Liste der Publikationen des Instituts aus dem Jahre 2020
Almstedt K & S Mendoza & M Otto & M J Battista & J Steetskamp & A S Heimes & S Krajnak & A Poplawski & A Gerhold-Ay & A Hasenburg & C Denkert & M Schmidt (2020)
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
in: Breast Cancer Research and Treatment (182)
10.1007/s10549-020-05688-1
Amgad M & E S Stovgaard & E Balslev & J Thagaard & W Chen & S Dudgeon & A Sharma & J K Kerner & C Denkert & Y Yuan & K AbdulJabbar & S Wienert & P Savas & L Voorwerk & A H Beck & A Madabhushi & J Hartman & M M Sebastian & H M Horlings & J Hudeček & F Ciompi & D A Moore & R Singh & E Roblin & M L Balancin & M-C Mathieu & J K Lennerz & P Kirtani & I-C Chen & J P Braybrooke & G Pruneri & S Demaria & S Adams & S J Schnitt & S R Lakhani & F Rojo & L Comerma & S S Badve & M Khojasteh & W F Symmans & C Sotiriou & P Gonzalez-Ericsson & K L Pogue-Geile & R S Kim & D L Rimm & G Viale & S M Hewitt & J M S Bartlett & F Penault-Llorca & S Goel & H-C Lien & S Loibl & Z Kos & S Loi & M G Hanna & S Michiels & M Kok & T O Nielsen & A J Lazar & Z Bago-Horvath & L F S Kooreman & J A W M van der Laak & J Saltz & B D Gallas & U Kurkure & M Barnes & R Salgado & L A D Cooper & International Immuno-Oncology Biomarker Working Group (2020)
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
in: NPJ breast cancer (6)
10.1038/s41523-020-0154-2
Bräutigam K & J Lindner & J Budczies & S Pahl & A Kunitz & I Melcher & P Wust & M Nebrig & A Baur & C Denkert & B Pfitzner (2020)
PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis
in: Annals of Diagnostic Pathology (44)
10.1016/j.anndiagpath.2019.151442
Denkert C (2020)
[Immunoncology and tumor infiltrating lymphocytes-new strategies for therapy and diagnosis of breast cancer]
in: Der Pathologe (41)
10.1007/s00292-020-00783-y
Derigs M & A Pehl & J Riera-Knorrenschild & R Hofmann & A Hegele (2020)
Burkitt's lymphoma of the prostate presenting as acute urinary retention: a case report
in: BMC urology (20)
10.1186/s12894-020-00616-3
Ehrenreich J & M Bette & A Schmidt & M Roeßler & U Bakowsky & U W Geisthoff & B A Stuck & R Mandic (2020)
Evaluation of digital image analysis as a supportive tool for the stratification of head and neck vascular anomalies
in: European archives of oto-rhino-laryngology (277)
10.1007/s00405-020-06097-2
Fülber I & K Peer & E Maurer & D K Bartsch & J Görlach & J N Göbel & M Roeßler & K Holzer (2020)
Two giant retroperitoneal schwannomas mimicking adrenal malignancy - a case report
in: Innovative Surgical Sciences (5)
10.1515/iss-2020-0008
Gonzalez-Ericsson P I & E S Stovgaard & L F Sua & E Reisenbichler & Z Kos & J M Carter & S Michiels & J Le Quesne & T O Nielsen & A-V Laenkholm & S B Fox & J Adam & J M Bartlett & D L Rimm & C Quinn & D Peeters & M V Dieci & A Vincent-Salomon & I Cree & A I Hida & J M Balko & H R Haynes & I Frahm & G Acosta-Haab & M Balancin & E Bellolio & W Yang & P Kirtani & T Sugie & A Ehinger & C A Castaneda & M Kok & H McArthur & K Siziopikou & S Badve & S Fineberg & A Gown & G Viale & S J Schnitt & G Pruneri & F Penault-Llorca & S Hewitt & E A Thompson & K H Allison & W F Symmans & A M Bellizzi & E Brogi & D A Moore & D Larsimont & D A Dillon & A Lazar & H Lien & M P Goetz & G Broeckx & K El Bairi & N Harbeck & A Cimino-Mathews & C Sotiriou & S Adams & S-W Liu & S Loibl & I-C Chen & S R Lakhani & J W Juco & C Denkert & E F Blackley & S Demaria & R Leon-Ferre & O Gluz & D Zardavas & K Emancipator & S Ely & S Loi & R Salgado & M Sanders & International Immuno-Oncology Biomarker Working Group (2020)
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
in: The Journal of Pathology (250)
10.1002/path.5406
Gremke N & P Polo & A Dort & J Schneikert & S Elmshäuser & C Brehm & U Klingmüller & A Schmitt & H C Reinhardt & O Timofeev & M Wanzel & T Stiewe (2020)
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
in: Nature Communications (11)
10.1038/s41467-020-18504-7
Guo S & S Loibl & G von Minckwitz & S Darb-Esfahani & B Lederer & C Denkert (2020)
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy
in: Cancer Research and Treatment (52)
10.4143/crt.2019.497
Hänze J & P Rexin & P Jakubowski & H Schreiber & H Heers & S Lingelbach & R Kinscherf & E Weihe & R Hofmann & A Hegele (2020)
Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density
in: Urologic Oncology (38)
10.1016/j.urolonc.2018.07.019
Huber M & C U Brehm & T M Gress & M Buchholz & B Alashkar Alhamwe & E P von Strandmann & E P Slater & J W Bartsch & C Bauer & M Lauth (2020)
The Immune Microenvironment in Pancreatic Cancer
in: International Journal of Molecular Sciences (21)
10.3390/ijms21197307
Hudeček J & L Voorwerk & M van Seijen & I Nederlof & M de Maaker & J van den Berg & K K van de Vijver & K Sikorska & S Adams & S Demaria & G Viale & T O Nielsen & S S Badve & S Michiels & W F Symmans & C Sotiriou & D L Rimm & S M Hewitt & C Denkert & S Loibl & S Loi & J M S Bartlett & G Pruneri & D A Dillon & M C U Cheang & A Tutt & J A Hall & Z Kos & R Salgado & M Kok & H M Horlings & International Immuno-Oncology Biomarker Working Group (2020)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
in: NPJ breast cancer (6)
10.1038/s41523-020-0155-1
Jank P & C Gehlhaar & L Bianca & F Caterina & S Andreas & T Karn & F Marmé & H-P Sinn & M van Mackelenbergh & B Sinn & D-M Zahm & B Ingold-Heppner & C Schem & E Stickeler & P A Fasching & V Nekljudova & E T Taube & F Heppner & V Müller & C Denkert & S Loibl (2020)
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
in: PloS One (15)
10.1371/journal.pone.0238021
Karn T & T Meissner & K E Weber & C Solbach & C Denkert & K Engels & P A Fasching & B V Sinn & I Schrader & J Budczies & F Marmé & V Müller & U Holtrich & B Gerber & C Schem & B M Young & C Hanusch & E Stickeler & J Huober & M van Mackelenbergh & B Leyland-Jones & T Fehm & V Nekljudova & M Untch & S Loibl (2020)
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial
in: Clinical Cancer Research (26)
10.1158/1078-0432.CCR-19-1954
Karn T & C Denkert & K E Weber & U Holtrich & C Hanusch & B V Sinn & B W Higgs & P Jank & H P Sinn & J Huober & C Becker & J-U Blohmer & F Marmé & W D Schmitt & S Wu & M van Mackelenbergh & V Müller & C Schem & E Stickeler & P A Fasching & C Jackisch & M Untch & A Schneeweiss & S Loibl (2020)
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
in: Annals of Oncology (31)
10.1016/j.annonc.2020.05.015
Karsten M M & M H Beck & A Rademacher & J Knabl & J-U Blohmer & J Jückstock & J C Radosa & P Jank & B Rack & W Janni (2020)
VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
in: Scientific Reports (10)
10.1038/s41598-020-59823-5
Kos Z & E Roblin & R S Kim & S Michiels & B D Gallas & W Chen & K K van de Vijver & S Goel & S Adams & S Demaria & G Viale & T O Nielsen & S S Badve & W F Symmans & C Sotiriou & D L Rimm & S Hewitt & C Denkert & S Loibl & S J Luen & J M S Bartlett & P Savas & G Pruneri & D A Dillon & M C U Cheang & A Tutt & J A Hall & M Kok & H M Horlings & A Madabhushi & J van der Laak & F Ciompi & A-V Laenkholm & E Bellolio & T Gruosso & S B Fox & J C Araya & G Floris & J Hudeček & L Voorwerk & A H Beck & J Kerner & D Larsimont & S Declercq & G Van den Eynden & L Pusztai & A Ehinger & W Yang & K AbdulJabbar & Y Yuan & R Singh & C Hiley & M A Bakir & A J Lazar & S Naber & S Wienert & M Castillo & G Curigliano & M-V Dieci & F André & C Swanton & J Reis-Filho & J Sparano & E Balslev & I-C Chen & E I S Stovgaard & K Pogue-Geile & K R M Blenman & F Penault-Llorca & S Schnitt & S R Lakhani & A Vincent-Salomon & F Rojo & J P Braybrooke & M G Hanna & M T Soler-Monsó & D Bethmann & C A Castaneda & K Willard-Gallo & A Sharma & H-C Lien & S Fineberg & J Thagaard & L Comerma & P Gonzalez-Ericsson & E Brogi & S Loi & J Saltz & F Klaushen & L Cooper & M Amgad & D A Moore & R Salgado & International Immuno-Oncology Biomarker Working Group (2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
in: NPJ breast cancer (6)
10.1038/s41523-020-0156-0
Kulbe H & O Klein & Z Wu & E T Taube & W Kassuhn & D Horst & S Darb-Esfahani & P Jank & S Abobaker & F Ringel & A du Bois & F Heitz & J Sehouli & E I Braicu (2020)
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging
in: Cancers (12)
10.3390/cancers12082000
Laakmann E & I Witzel & T Neunhöffer & R Weide & M Schmidt & T-W Park-Simon & V Möbus & C Mundhenke & A Polasik & K Lübbe & T Hesse & K Riecke & M Thill & P A Fasching & C Denkert & T Fehm & V Nekljudova & J Rey & S Loibl & V Müller (2020)
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
in: Cancers (12)
10.3390/cancers12102787
Loehrer P A & L Timmermann & A Pehl & C I Bien & A Pfestroff & D J Pedrosa (2020)
Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report
in: BMC neurology (20)
10.1186/s12883-020-01788-z
Mandic R & A Agaimy & D Pinto-Quintero & K Roth & A Teymoortash & H Schwarzbach & C G Stoehr & F R Rodepeter & B A Stuck & M Bette (2020)
Aberrant Expression of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in Warthin Tumors
in: Cancers (12)
10.3390/cancers12051112
Massa C & T Karn & C Denkert & A Schneeweiss & C Hanusch & J-U Blohmer & D-M Zahm & C Jackisch & M van Mackelenbergh & J Thomalla & F Marme & J Huober & V Müller & C Schem & A Mueller & E Stickeler & K Biehl & P A Fasching & M Untch & S Loibl & K Weber & B Seliger (2020)
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
in: Journal for Immunotherapy of Cancer (8)
10.1136/jitc-2020-001261
Ojasalu K & C Brehm & K Hartung & M Nischak & F Finkernagel & P Rexin & A Nist & E Pavlakis & T Stiewe & J M Jansen & U Wagner & S Gattenlöhner & A Bräuninger & S Müller-Brüsselbach & S Reinartz & R Müller (2020)
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
in: Molecular Oncology (14)
10.1002/1878-0261.12749
Pergande M & S Motameny & Ö Özdemir & M Kreutzer & H Wang & H-S Daimagüler & K Becker & M Karakaya & H Ehrhardt & N Elcioglu & S Ostojic & C-M Chao & A Kawalia & Ö Duman & A Koy & A Hahn & J Reimann & K Schoner & A Schänzer & J H Westhoff & E M C Schwaibold & M Cossee & M Imbert-Bouteille & H von Pein & G Haliloglu & H Topaloglu & J Altmüller & P Nürnberg & H Thiele & R Heller & S Cirak (2020)
The genomic and clinical landscape of fetal akinesia
in: Genetics in Medicine (22)
10.1038/s41436-019-0680-1
Pohl-Rescigno E & J Hauke & S Loibl & V Möbus & C Denkert & P A Fasching & M Kayali & C Ernst & N Weber-Lassalle & C Hanusch & H Tesch & V Müller & J Altmüller & H Thiele & M Untch & K Lübbe & P Nürnberg & K Rhiem & J Furlanetto & B Lederer & C Jackisch & V Nekljudova & R K Schmutzler & A Schneeweiss & E Hahnen (2020)
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial
in: JAMA oncology (6)
10.1001/jamaoncol.2020.0007
Rüger A M & A Schneeweiss & S Seiler & H Tesch & M van Mackelenbergh & F Marmé & K Lübbe & B Sinn & T Karn & E Stickeler & V Müller & C Schem & C Denkert & P A Fasching & V Nekljudova & T Garfias-Macedo & G Hasenfuß & W Haverkamp & S Loibl & S von Haehling (2020)
Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial
in: Journal of the American Heart Association (9)
10.1161/JAHA.120.018143
Schmid P & J Cortes & L Pusztai & H McArthur & S Kümmel & J Bergh & C Denkert & Y H Park & R Hui & N Harbeck & M Takahashi & T Foukakis & P A Fasching & F Cardoso & M Untch & L Jia & V Karantza & J Zhao & G Aktan & R Dent & J O'Shaughnessy & KEYNOTE-522 Investigators (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
in: The New England Journal of Medicine (382)
10.1056/NEJMoa1910549
Schoner K & M Witsch-Baumgartner & J Behunova & R Petrovic & R Bald & S G Kircher & A Ramaswamy & B Kluge & M Meyer-Wittkopf & R Schmitz & B Fritz & J Zschocke & F Laccone & H Rehder (2020)
Smith-Lemli-Opitz syndrome - Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern
in: Birth Defects Research (112)
10.1002/bdr2.1620
Sinn M & B V Sinn & D Treue & U Keilholz & F Damm & R Schmuck & P Lohneis & F Klauschen & J K Striefler & M Bahra & H Bläker & S Bischoff & U Pelzer & H Oettle & H Riess & J Budczies & C Denkert (2020)
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
in: Clinical Cancer Research (26)
10.1158/1078-0432.CCR-19-3034
Sonnenblick A & M Salmon-Divon & R Salgado & E Dvash & N Pondé & T Zahavi & A Salmon & S Loibl & C Denkert & H Joensuu & L Ameye & G Van den Eynden & P-L Kellokumpu-Lehtinen & A Azaria & S Loi & S Michiels & F Richard & C Sotiriou (2020)
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
in: International Journal of Cancer (147)
10.1002/ijc.32859
Stathopoulos P & A Pehl & L P Breitling & C Bauer & T Grote & T M Gress & C Denkert & U W Denzer (2020)
Endoscopic ultrasound-fine needle biopsies of pancreatic lesions: Prospective study of histology quality using Franseen needle
in: World Journal of Gastroenterology (26)
10.3748/wjg.v26.i37.5693
Steven A & M Friedrich & P Jank & N Heimer & J Budczies & C Denkert & B Seliger (2020)
What turns CREB on? And off? And why does it matter?
in: Cellular and molecular life sciences (77)
10.1007/s00018-020-03525-8
Werutsky G & M Untch & C Hanusch & P A Fasching & J-U Blohmer & S Seiler & C Denkert & H Tesch & C Jackisch & B Gerber & A Schneeweiss & T Link & D Krug & J Huober & K Rhiem & T Kühn & V Vladimirova & V Nekljudova & S Loibl (2020)
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials
in: European Journal of Cancer (130)
10.1016/j.ejca.2020.02.015
Westhoff C C & P Jank & C O Jacke & U-S Albert & S Ebrahimsade & P J Barth & R Moll (2020)
Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast
in: Virchows Archiv (477)
10.1007/s00428-020-02835-3
Wilczynski A & C Görg & N Timmesfeld & A Ramaswamy & A Neubauer & A Burchert & C Trenker (2020)
Value and Diagnostic Accuracy of Ultrasound-Guided Full Core Needle Biopsy in the Diagnosis of Lymphadenopathy: A Retrospective Evaluation of 793 Cases
in: Journal of Ultrasound in Medicine (39)
10.1002/jum.15134